Table 2.

Age, neurological proficiency scores, and biochemical characteristics by disease status according to the WHO discrete criteria

Characteristics	Konzo	Non-Konzo	p-value**
Age, Years (21/19)*
Mean (SD)	9.2 (3.2)	9.3 (2.9.0)
Median (IQR)	9.0 (7.0 – 11.0)	8 (7.0 – 12.0)	0.71
BOT-2 motor score (21/16)*
Mean (SD)	21.2 (2.30)	35.8 (7.00)
Median (IQR)	20.0 (20.0 – 21.0)	33.5 (31.5 – 41.5)	0.00
KABC-II cognition score (21/16)*
Mean (SD)	53.48 (6.78)	61.8 (10.0)
Median (IQR)	52.0 (49.0 – 57.0)	57.5 (54.5 – 68.0)	0.01
Albumin, μmol/L (20/15)*
Mean (SD)	469.9 (116.1)	606.8 (61.5)
Median (IQR)	462.9 (409.2 – 527.2)	619.4 (540.0 – 675.3)	0.00
Free-T4, ng/dL (17/19)*
Mean (SD)	1.09 (0.22)	1.12 (0.25)
Median (IQR)	1.10 (0.90 – 1.20)	1.10 (0.90 – 1.30)	0.70
TSH, μIU/mL (18/19)*
Mean (SD)	3.88 (2.13)	3.64 (1.57)
Median (IQR)	3.33 (2.42 – 5.02)	3.48 (2.24 – 4.94)	0.98

^*Indicates konzo/non-konzo N ratio;

^**Wilcoxon rank-sum test